Abbisko Cayman (HKSE:02256) Other Stockholders Equity : HK$397.4 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Abbisko Cayman Other Stockholders Equity?

Abbisko Cayman's Other Stockholders Equity for the quarter that ended in Jun. 2024 was HK$397.4 Mil.

Abbisko Cayman's quarterly Other Stockholders Equity declined from Jun. 2023 (HK$456.7 Mil) to Dec. 2023 (HK$432.2 Mil) and declined from Dec. 2023 (HK$432.2 Mil) to Jun. 2024 (HK$397.4 Mil).

Abbisko Cayman's annual Other Stockholders Equity increased from Dec. 2021 (HK$179.1 Mil) to Dec. 2022 (HK$361.2 Mil) and increased from Dec. 2022 (HK$361.2 Mil) to Dec. 2023 (HK$432.2 Mil).

Abbisko Cayman Other Stockholders Equity Historical Data

The historical data trend for Abbisko Cayman's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Other Stockholders Equity Chart

Abbisko Cayman Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

-510.79

75.86

179.14

361.19

432.20

Abbisko Cayman Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Stockholders Equity	Get a 7-Day Free Trial				2,908.86	361.19	456.68	432.20	397.39

Abbisko Cayman Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Abbisko Cayman Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbisko Cayman Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (HKSE:02256) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

8ZD:Germany

Address

Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

https://www.abbisko.com

Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Executives

Xu Yao-chang	2101 Beneficial owner
Yu Hongping	2501 Other
Chen Zhui	2501 Other
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Shi Yi	2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited	2301 Trustee
Qiming Corporate Gp Vi, Ltd.	2201 Interest of corporation controlled by you
Futu Trustee Limited	2301 Trustee
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
Yu Hongping	2501 Other
Morgan Stanley	2201 Interest of corporation controlled by you
Fullerton Management Pte Ltd
Computershare Hong Kong Trustees Limited	2301 Trustee
Morgan Stanley Investments (uk)	2201 Interest of corporation controlled by you
Morgan Stanley International Limited	2201 Interest of corporation controlled by you

Abbisko Cayman Headlines

No Headlines